Akamis Bio

Akamis Bio is a biotech company in London, United Kingdom, founded in 2020. It has raised $90.0M across 2 rounds, most recently a $60.0M Series A in December 2024.

Headquarters
London
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$90.0M
Last Round
$60.0M Series ADec 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Akamis Bio is developing oncolytic immunotherapies to expand treatment options for people living with colorectal cancer. The company aims to create medicines that can directly attack a patient's tumor while potentially reducing the need for surgical interventions, helping patients preserve colorectal function and improve their quality of life. A team of scientists, clinicians, and innovators, Akamis Bio is working to transform the standard of care for colorectal cancer through its oncolytic immunotherapy programs.

Summary

It lists 11–50 employees. It has raised $90.0M in total across 2 rounds, most recently a $60.0M Series A round in Dec 2024. Investors include Sedgwick Yard, ARCH Venture Partners and Parker Institute for Cancer Immunotherapy.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ADec 2024
$60.0M

Sign up to see all 2 events

Funding: Convertible Note through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Akamis Bio on Indexed.vc
<a href="https://indexed.vc/companies/akamis-bio"><img src="https://indexed.vc/api/badge/company/akamis-bio" alt="Akamis Bio on Indexed.vc" width="260" height="76" /></a>